VERTEX PHARMACEUTICALS INCORPORATED Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 427 USD | +1.00% |
|
+6.29% | +5.14% |
| 05-10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
| 05-07 | FOMO is Back |  |
ETFs positioned on Vertex Pharmaceuticals Incorporated
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.22% | 205 M€ | -.--% | ||
| 0.22% | 264 M€ | -.--% | - | |
| 0.22% | 187 M€ | +9.15% | - | |
| 0.22% | 477 M€ | +11.46% | ||
| 0.22% | 20 M€ | +1.59% | - | |
| 0.22% | 115 M€ | +2.02% | - | |
| 0.21% | 57 M€ | +20.20% | - | |
| 0.20% | 7 M€ | +0.11% | - | |
| 0.20% | 7 M€ | +5.63% | - | |
| 0.20% | 32 M€ | +1.41% | - | |
| 0.20% | 17 M€ | +6.07% | - | |
| 0.19% | 9 M€ | +9.18% | - | |
| 0.19% | 37 M€ | -.--% | ||
| 0.18% | 14 M€ | +16.19% | - | |
| 0.17% | 15 M€ | -1.62% | - | |
| 0.17% | 284 M€ | -.--% | ||
| 0.16% | 607 M€ | +0.05% | ||
| 0.16% | 1,166 M€ | +0.26% | ||
| 0.16% | 206 M€ | -.--% | ||
| 0.16% | 23 M€ | -.--% | - | |
| 0.16% | 786 M€ | -.--% | ||
| 0.16% | 0 M€ | 0.00% | - | |
| 0.16% | 2,517 M€ | +12.10% | - | |
| 0.15% | 283 M€ | +19.00% | ||
| 0.14% | 571 M€ | +7.16% | - | |
| 0.14% | 414 M€ | +11.90% | - | |
| 0.14% | 1,006 M€ | -.--% |
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Calendar
15/05/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
422.8
USD
Average target price
462.1
USD
Spread / Average Target
+9.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.14% | 109B | |
| +11.66% | 105B | |
| +0.09% | 22.25B | |
| -12.12% | 22.09B | |
| -7.91% | 18.68B | |
| -38.36% | 17.58B | |
| -9.54% | 16.85B | |
| +4.63% | 13.76B | |
| +37.03% | 12.46B | |
| +291.89% | 8.12B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated
